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or the most part unknown. Of >100 countries that are not
apacitated to report TB resistance surveillance to WHO,
he majority reside in Africa. Global estimates are there-
ore extrapolated from different sources. The South African
DR/XDR TB burden is similarly estimated and for the most
art incomplete.
Discussion: An MDR TB survey of 2001 (MRC) estimated
he burden of MDR TB at levels between 1—3% with isolated
otspots. It was not designed to estimate XDR TB and was
classic ‘‘point prevalence’’ study that sampled from lim-
ted sites. KZN has been the only South African province
ith an expanded portfolio of routine susceptibility test-
ng for second-line drugs for all clinical isolates. ‘‘XDR’’ TB
as been documented since the late 1980’s and described in
reatment cohorts admitted for care. These results will be
resented. The TFO however recorded the highest cluster of
ndividual cases ever reported and exposed the limitations of
he current surveillance strategy that depended on periodic
ross-sectional surveys. As a result the MRC has embarked
n a rapid surveillance project identifying regions in the
rovince where XDR TB has been identiﬁed and targeting
hese settings for an in-patient and out-patient surveillance
roject.
Conclusions: The recommendation for a continuous,
xpanded, country-wide surveillance system is self-evident
f only to accurately inform the currently straining program-
atic management of drug-resistant TB and to provide the
arly warning signals of programmatic failure.
oi:10.1016/j.ijid.2008.05.126
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t is estimated that there were 149,615 (95% CLs,
14,780—217,921) incident MDR-TB cases in South East Asia
n 2006, 74% were in India while there were 152,694 (95%
Ls, 119,886—188,014) incident MDR-TB cases in the the
estern Paciﬁc region in 2006, with almost 85% of these
ases estimated to be in China. The proportion of XDR-TB
mong MDR-TB was highest in Japan, 30.9% followed by
4.6% in Hong Kong, SAR, 3.4% Philippines, 1.8% Korea, 1%
angladesh, and one case each in Vietnam, India, China and
epal. Population-based studies still have to be undertaken
o know the real magnitude of XDR-TB.
Extensively drug-resistant TB (XDR-TB) was ﬁrst
escribed in 2006 in 40 0f 49 countries studied with
% of MDR-TB isolates in the USA, 19% in Latvia and 15% in
orea among chronic cases. An outbreak of XDR-TB among
4 patients with a high prevalence of HIV in South Africa
eported in 2006 was characterized by high early mortality
f 98% and nosocomial transmission as well as transmision
n the community. This outbreak demonstrated that XDR-TB
s a threat to both TB and HIV control and emphasized
he need for infection control measures in health facility
ettings.
XDR, deﬁned as MDR-TB plus simultaneous resistance
o a ﬂuoroquinolone and an injectable second line anti-
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B drug, showed a cure rate that was signiﬁcantly low
nd a failure rate that was high compared to other MDR-
B patients in Latvia. To respond to this crisis, the WHO
lobal Response plan 2007—2008 emphasized the need to
trengthen basic DOTS and HIV programs, to scale up the pro-
rammatic management of MDR-TB, strengthen laboratory
ervices to support M(X)DR-TB diagnosis, expand M(X)DR-TB
urveillance to study trends and link with HIV, foster sound
nfection control, promote research on the development
f new diagnostics, drugs, and vaccines. Much like MDR-
B which is the consequence of poor DOTS, XDR-TB is the
onsequence of poor MDR-TB management.
oi:10.1016/j.ijid.2008.05.127
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ccording to the inverse-care law, the highest standard of
are is least available to those most in need. Diagnosis of
rug-resistant TB has long been a clear example of this
henomenon. In recent years a number of candidate diag-
ostic tests have been developed in both the academic and
ommercial sectors which present potential opportunities
o aggressively address this inequity. This talk will discuss
ome of the currently available tools that are suitable for
esource-limited settings, their relative merits and draw-
acks, and a number of implementation challenges common
o all, drawing on experience from Peru.
oi:10.1016/j.ijid.2008.05.128
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B in Peru has been known since the pre-hispanic period in
ommies.
Peru and Haiti has had the highest rate of prevalence in
merica (>160× 105 per habitant), where more than 65% of
ases of pulmonary TB has sputum positive.
Recently, the WHO recognized the Peruvian DOT as one
f the best worldwide programs to have reach the two goals
f the DOT (Diagnosis in more than 90% cases and cure rate
ore than 90%) decreasing the incidence in 5-6% per year in
he last 10 years.
However, in the shanty towns of Lima, the rate of MDR-
B has being increasing in an important way, spreading to
rban parts of the big cities. Leaving in the North of Lima
as been noted as a risk factor, where the primary rate of
DR TB is 6%, while in the South of Lima is just 2%. The most
now risk factors are having an intra-domiciliary TB contact
nd a treatment failure in the second of month of the ﬁrst
ine therapy; others include Diabetes Mellitus, AIDS/HIV and
ealth care workers. Also, 10-15% of MDR TB cases are XDR.
